Christian Richard is an SVP, Research at Tekla Capital Management LLC, an advisor for four healthcare-focused closed-end investment funds since March of 2015. Previously, Mr. Richard was a Partner/Head of Research for Merlin Biomed Private Equity/Merlin Nexus for 12 years. Merlin Nexus is a cross-over life sciences fund focused on negotiated transactions in both late-stage private and public companies. Prior to Merlin Nexus, Mr. Richard spent five years in the Allergy/Immunology Group at the Schering-Plough Research Institute. He has a B.S. in Cellular and Molecular Biology from Purchase College and both an M.S. in Biochemistry and an M.B.A. in Finance from NYU. Mr. Richard is also on the board of Bioclin Therapeutics, Inc. and was formerly on the Board of Merus N.V. as an observer.